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SUMMARY
It has been suggested that oxidative stress may play a role in the pathophysiology of
heart failure. However, little is known about the clinical relationship between oxidative
stress and left ventricular dilatation after acute myocardial infarction (AMI). We prospec-
tively studied 28 consecutive patients, successfully treated with primary coronary angio-
plasty, after their first AMI. To evaluate oxidative stress, plasma oxidized low-density
LDL levels (U/mL) were measured serially 1 day, 7 days, 14 days, 30 days, and 90 days
after the onset of AMI using a specific sandwich enzyme-linked immunosorbent assay.
Left ventriculography and coronary angiography were obtained in all patients 3 months
after the AMI and infarct-related arteries were all patent. Peak plasma oxidized LDL lev-
els were seen 7 days after AMI (after 1 day: 14.7±1.5, 7 days: 21.0±2.8, 14 days:
20.2±2.8, 30 days: 18.3±2.5, 90 days: 16.5±2.3 U/mL). Plasma oxidized LDL levels 7
days after AMI were significantly correlated with left ventricular end-diastolic volume
(115±7 mL; r=0.54, P=0.0025) and end-systolic volume (58±5 mL; r=0.49, P=0.008) 3
months after the AMI. Moreover, they were also correlated with end-diastolic volume
index (68±4 mL/m2, r=0.40, P<0.05). However, no correlation was seen between peak
plasma oxidized LDL levels and ejection fraction. These findings suggest that oxidative
stress may play an important role in the development and progression of left ventricular
remodeling after AMI. (Jpn Heart J 2002; 43: 203-209)
Key words: Left ventricular remodeling, Lipoproteins, Myocardial infarction, Oxidative
stress
LEFT ventricular remodeling after acute myocardial infarction (AMI) is a seri-
ous problem because it leads to progressive left ventricular dilatation, impaired
cardiac performance, and chronic heart failure. Previous studies have demon-
strated that infarct size1-2) and persistent occlusion of the infarct-related artery3-5)
are two major factors that promote ventricular remodeling. However, multiple
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factors may in fact contribute to left ventricular remodeling at different stages,
from the time of coronary occlusion until the development of ventricular dilata-
tion and dysfunction.6-7) The assessment of the relative role and determinants in
the natural history of the left ventricular remodeling process is of crucial impor-
tance for planning risk stratification and management strategies.
Oxidative stress and the production of intracellular reactive oxygen species
have been implicated in the pathogenesis of cardiovascular disease. Recent data
have suggested that oxidant product levels increase significantly in patients with
heart failure.8-9) In particular, atherogenic oxidized low-density lipoprotein
(LDL)10-13) can be measured in vivo and is useful as a diagnostic marker for car-
diovascular disease.14-16) However, the time course of oxidative stress after AMI
and its clinical significance remain uncertain. In this prospective study, we inves-
tigated the serial changes in plasma oxidized LDL levels as one of the oxidative
markers and their correlation with clinical variables, especially with left ventric-
ular volume after AMI.
METHODS
Study population: We prospectively studied 28 consecutive AMI patients (24
men and 4 women; mean age, 61±2 years) treated at our institution between
August 1998 and March 1999. All patients had ischemic chest pain with ST-seg-
ment elevation on the electrocardiogram and were admitted within 6 hours. Cor-
onary angiography was performed on all patients, after informed consent was
obtained, and 22 infarct-related arteries were found to be completely occluded.
Primary percutaneous transluminal coronary angioplasty (PTCA) was performed
using conventional techniques. During the procedures, the patients received an
initial bolus injection of heparin (100 units/kg [body weight]) and additional hep-
arin (2000 units) each hour. Investigators attempted to achieve an optimal result
with conventional balloon angioplasty, defined as residual stenosis of <25% of
the luminal diameter, according to a visual estimate. Stent placement was permit-
ted as a bailout procedure in the case of abrupt or threatened closure, and was
defined as a dissection. Angiographic success was defined as <50% diameter nar-
rowing after the procedure. Follow up coronary angiography and left ventriculo-
graphy were performed 3 months after the AMI. None of the patients had major
adverse cardiac events, renal failure, or infectious disease during the 3 month
period following the AMI. Left ventricular ejection fraction, volume, and volume
index were evaluated by left ventriculography using an area-length method.
Blood sampling: Blood samples were obtained from the antecubital vein serially
1 day, 1 week, 2 weeks, 1 month, and 3 months after the onset of AMI. All blood
samples were collected in the fasting state. Serum was obtained by centrifugation
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and stored at 4°C until use. To determine maximum creatine kinase-MB and C-
reactive protein levels, blood samples were also obtained every 6 hours and every
day, respectively, until peak levels were attained.
Oxidized LDL assay: Plasma oxidized LDL concentrations were measured by a
sandwich enzyme-linked immunosorbent assay using a specific monoclonal anti-
body against oxidized phosphatidylcholine and anti-human apolipoprotein B
antibody.17-18) Before each assay, the plasma samples were diluted with dilution
buffer (1/250), and DLH3-coated plates were washed 3 times with phosphate-
buffered saline and patted dry. Dilution buffer (100 µL) was added to the wells of
the plates and 20 µL of patient or calibration sample was added to wells and
mixed with dilution buffer. The plates were incubated for 2 hours at 37°C. After
washing 5 times with wash buffer, horseradish peroxidase-labeled anti-human
apolipoprotein B-100 goat IgG was added to each well and the plates were incu-
bated for 1 hour at 37°C. After washing 5 times with wash buffer, 100 µL of tet-
ramethylbenzidine solution was added to the wells, and the plates were incubated
for 30 minutes at 37°C. To stop the reaction, 100 µL of 1M H2SO4 was added, and
the absorbance at 450 nm was measured with a MTP-120 plate reader (Corona
Electric Co., Ltd., Tokyo). The levels of plasma oxidized LDL were expressed in
arbitrary units (U/mL). This assay has good sensitivity (detection limit: 1 U/mL),
reproducibility (coefficient variation <10%), and accuracy (recovery: 90.6-
103.8%). The dosages of heparin did not affect the measurements
Statistical analysis: Data are expressed as mean±SEM. For changes in oxidized
LDL levels, a nonparametric analysis (Wilcoxon signed rank test) was per-
formed. A simple linear regression line was calculated to assess the correlations
between two parameters. Stepwise regression analysis was performed to deter-
mine whether clinical variables were independently related to left ventricular vol-
ume. All statistical analyses were performed using StatView Version 4.5 (Abacus
Concepts, Inc., Berkeley, CA). Statistical significance was defined as P<0.05.
RESULTS
The AMI among the 28 patients included 11 anteroseptal, 10 inferior, and 7
lateral AMI. No patient had any previous myocardial infarction, however 7
patients had hypertension (25%), 10 hyperlipidemia (36%), and 5 diabetes melli-
tus (18%). The mean of the maximum creatine kinase-MB was 322±48 IU/L and
the mean of the maximum C-reactive protein was 5.56±0.72 mg/dL.
Figure 1 shows the changes in plasma oxidized LDL levels in patients with
AMI from 1 to 90 days after the onset. Peak elevation in plasma oxidized LDL
was found on day 7 (21.0±2.4 U/mL), which was significantly higher than that on
day 1 (14.1±1.6 U/mL). The day on which plasma oxidized LDL levels reached
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their maximum in each patient was distributed between days 7 and 30 after the
onset of AMI.
Correlations between plasma oxidized LDL levels and laboratory data: As shown
in Figure 2, a significant positive correlation was found between peak oxidized
Figure 1.   Serial changes in plasma oxidized LDL after the onset of AMI. Circles: mean plasma oxidized LDL in
AMI patients. *P<0.0001 compared with plasma oxidized LDL level on day 1.
Figure 2.   Correlations between oxidized LDL levels and laboratory data. A: A significant positive correlation was found between
peak oxidized LDL and peak creatine kinase-MB (r=0.58, P=0.001). B: A significant positive correlation was also found between
peak oxidized LDL and peak C-reactive protein (r=0.61, P=0.0004).
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LDL and peak creatine kinase-MB levels (r=0.41, P=0.001). A significant posi-
tive correlation was also observed between peak oxidized LDL and peak C-reac-
tive protein levels (r=0.61, P=0.0004).
Correlations between plasma oxidized LDL levels and left ventricular volume:
End-diastolic and end-systolic volume after 3 months were 115±7 mL and 58±5
mL, respectively. In Figure 3, a significant positive correlation was found
between peak oxidized LDL and end-diastolic and end-systolic volume, respec-
tively. Moreover, peak oxidized LDL levels were also correlated with end-dias-
tolic volume index (68±4 mL/m2, r=0.40, P<0.05). However, no correlation was
seen between peak plasma oxidized LDL levels and ejection fraction (52±2%,
P=NS). Multivariate stepwise analyses were performed to find the major determi-
nants of end-diastolic and end-systolic volume using 4 variables: peak C-reactive
protein, peak creatine kinase-MB, peak oxidized LDL, and angiotensin-convert-
ing enzyme inhibitor therapy. These analyses revealed that only peak plasma oxi-
dized LDL was a significant independent predictor of both end-diastolic and end-
systolic volume.
DISCUSSION
The major findings in this study are that plasma oxidized LDL levels
increased significantly after AMI and the peak levels were significantly associ-
ated with end-diastolic and systolic volume 3 months after the AMI.
Plasma oxidized LDL levels have been found to be significantly elevated in
patients with coronary artery disease.15) The source of elevated oxidized LDL lev-
Figure 3.   Correlations between oxidized LDL and left ventricular volume. A: A significant positive correlation was found
between peak oxidized LDL and end-diastolic volume (r=0.54, P=0.0025). B: A significant correlation was found between
peak plasma oxidized LDL and end-systolic volume (r=0.49, P= 0.008).
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els may be back-diffusion from the arterial wall into blood.14-16) On the other
hand, Tsutamoto, et al reported transcardiac elevation of oxidized LDL levels in
patients with dilated cardiomyopathy with the same assay used in this study.19)
Their results suggest that elevated levels of plasma oxidized LDL are due to oxi-
dative stress in the failing heart. Overstretching of the myocardium leads to
enhanced generation of reactive oxygen species,8) and there is evidence of free
radical production in coronary artery disease.20) Therefore, the peak elevation in
oxidized LDL levels is thought to be due to increased myocardial oxidative stress
after AMI21) rather than back-diffusion from the coronary artery wall.
We observed a significant correlation between plasma oxidized LDL and
peak creatine kinase-MB as well as peak C-reactive protein, suggesting that peak
oxidized LDL levels may reflect damaged myocardium after AMI. Several vari-
ables have been identified that predict an increase in left ventricular volume after
AMI. These include infarct size and the patency of the infarct-related artery.1-5)
However, the role of oxidative stress, which may play an important role in heart
failure, has not been fully investigated after AMI. In the present study, peak oxi-
dized LDL levels were significantly correlated with end-diastolic and end-sys-
tolic volume and were the best predictor of left ventricular volume. This suggests
oxidative stress may affect left ventricular remodeling after AMI. 
In conclusion, this is the first study demonstrating that left ventricular dila-
tation after AMI is associated with a significant increase in plasma oxidized LDL
levels, which is likely to reflect oxidative stress in the heart. These feasible
approaches to quantify oxidative stress in damaged myocardium could be used to
predict left ventricular dilatation and to manage therapeutic strategies after AMI. 
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